DexCom
DXCM
$124.34
Share price
-9.91%
Change (1 day)
-0.47%
Change (1 year)
Categories
DexCom (DXCM) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $4.19 B
According to DexCom's latest financial reports the company's total liabilities are $4.19 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
DexCom - Total liabilities on balance sheet (from 2005 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $4.19 B | 28.71% |
| 2022-12-31 | $3.25 B | 12.75% |
| 2021-12-31 | $2.89 B | 17.34% |
| 2020-12-31 | $2.46 B | 62.92% |
| 2019-12-31 | $1.51 B | 20.73% |
| 2018-12-31 | $1.25 B | 158.45% |
| 2017-12-31 | $0.48 B | 307.31% |
| 2016-12-31 | $0.11 B | 68.08% |
| 2015-12-31 | $70.8 M | 59.46% |
| 2014-12-31 | $44.4 M | 15.63% |
| 2013-12-31 | $38.4 M | 32.41% |
| 2012-12-31 | $29 M | 81.25% |
| 2011-12-31 | $16 M | -1.06% |
| 2010-12-31 | $16.17 M | -75.27% |
| 2009-12-31 | $65.39 M | 3.22% |
| 2008-12-31 | $63.35 M | -9.69% |
| 2007-12-31 | $70.14 M | 808.01% |
| 2006-12-31 | $7.72 M | 5.62% |
| 2005-12-31 | $7.31 M | -90.7% |
| 2004-12-31 | $78.66 M | 47.41% |
| 2003-12-31 | $53.36 M | |
| 2001-12-31 | $17.57 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 2,254.30% | 🇺🇸 USA |
 Abbott Laboratories ABT | $34.38 B | 719.54% | 🇺🇸 USA |
 Medtronic MDT | $38.84 B | 825.67% | 🇮🇪 Ireland |
 Becton Dickinson BDX | $26.94 B | 542.08% | 🇺🇸 USA |
 Edwards Lifesciences EW | $2.64 B | -36.99% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | $0.63 B | -84.77% | 🇺🇸 USA |
 QuidelOrtho QDEL | $3.55 B | -15.22% | 🇺🇸 USA |
 West Pharmaceutical WST | $0.94 B | -77.39% | 🇺🇸 USA |